Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases
Authors:
- 24 November 2011
- journal article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 11 (1) , 51-62
Abstract
Sixty‐three dogs with multiple contemporaneous cutaneous mast cell tumours (MCTs) were identified. The aim of this study was to determine the significance of breed, concurrent dermatological condition; number of cutaneous MCTs, size, location, histological grade and mitotic index; completeness of excision (complete, close or incomplete); local recurrence, metastasis and adjuvant therapy for the prognostic evaluation of dogs with a unique disease presentation of multiple, simultaneously occurring cutaneous MCTs. On the basis of multivariable survival analysis, dogs with one recorded grade 3 MCT had shorter progression‐free survival (PFS) times (18.7 versus 2.2 months) and median survival times (MSTs) (24 versus 3 months). Dogs treated with adjuvant vinblastine/lomustine had a 16 times increased risk of dying. MSTs were found to be significantly longer in dogs with one recorded MCT on an extremity. For all dogs, the PFS (range 14–1835 days) and MSTs (range 28–1835 days) were not reached.Keywords
This publication has 28 references indexed in Scilit:
- Outcomes of Dogs with Grade 3 Mast Cell Tumors: 43 Cases (1997–2007)Journal of the American Animal Hospital Association, 2011
- Cutaneous mast cell tumours in dogsVeterinary Record, 2010
- Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in GlioblastomaStem Cells, 2010
- Breed and site predispositions of dogs with atopic dermatitis: a comparison of five locations in three continentsVeterinary Dermatology, 2010
- Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatmentVeterinary Dermatology, 2008
- Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisoneBMC Veterinary Research, 2008
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- Canine Mast Cell Tumors: Correlation of Apoptosis and Proliferation Markers with PrognosisJournal of Veterinary Internal Medicine, 2006
- Impact of Tumour Depth, Tumour Location and Multiple Synchronous Masses on the Prognosis of Canine Cutaneous Mast Cell TumoursJournal of Veterinary Medicine Series A, 2005
- Use of Kit Internal Tandem Duplications to Establish Mast Cell Tumor Clonality in 2 DogsJournal of Veterinary Internal Medicine, 2004